Activity Inference for Ambient Intelligence Through Handling Artifacts in a Healthcare Environment

Human activity inference is not a simple process due to distinct ways of performing it. Our proposal presents the SCAN framework for activity inference. SCAN is divided into three modules: (1) artifact recognition, (2) activity inference, and (3) activity representation, integrating three important elements of Ambient Intelligence (AmI) (artifact-behavior modeling, event interpretation and context extraction). The framework extends the roaming beat (RB) concept by obtaining the representation using three kinds of technologies for activity inference. The RB is based on both analysis and recognition from artifact behavior for activity inference. A practical case is shown in a nursing home where a system affording 91.35% effectiveness was implemented in situ. Three examples are shown using RB representation for activity representation. Framework description, RB description and CALog system overcome distinct problems such as the feasibility to implement AmI systems, and to show the feasibility for accomplishing the challenges related to activity recognition based on artifact recognition. We discuss how the use of RBs might positively impact the problems faced by designers and developers for recovering information in an easier manner and thus they can develop tools focused on the user

CIBERER : Spanish national network for research on rare diseases: A highly productive collaborative initiative

Altres ajuts: Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovación.CIBER (Center for Biomedical Network Research; Centro de Investigación Biomédica En Red) is a public national consortium created in 2006 under the umbrella of the Spanish National Institute of Health Carlos III (ISCIII). This innovative research structure comprises 11 different specific areas dedicated to the main public health priorities in the National Health System. CIBERER, the thematic area of CIBER focused on rare diseases (RDs) currently consists of 75 research groups belonging to universities, research centers, and hospitals of the entire country. CIBERER's mission is to be a center prioritizing and favoring collaboration and cooperation between biomedical and clinical research groups, with special emphasis on the aspects of genetic, molecular, biochemical, and cellular research of RDs. This research is the basis for providing new tools for the diagnosis and therapy of low-prevalence diseases, in line with the International Rare Diseases Research Consortium (IRDiRC) objectives, thus favoring translational research between the scientific environment of the laboratory and the clinical setting of health centers. In this article, we intend to review CIBERER's 15-year journey and summarize the main results obtained in terms of internationalization, scientific production, contributions toward the discovery of new therapies and novel genes associated to diseases, cooperation with patients' associations and many other topics related to RD research